Modulating effects of sensory and autonomic neuropeptides on murine splenocyte proliferation and cytokine secretion induced by Leishmania major

Immunopharmacology and Immunotoxicology

Volumn 21, Issue 3, 1999, Pages 507-526

  Ahmed, A A ^a   Mutt, V ^b   Nordlind, K ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; NEUROPEPTIDE; NEUROPEPTIDE Y; SOMATOSTATIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INBRED STRAIN; INTERFERON PRODUCTION; LEISHMANIA MAJOR; MOUSE; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; SENSORY NERVE; SKIN LEISHMANIASIS; SPLEEN CELL;

ANIMALIA; LEISHMANIA MAJOR; MURINAE;

EID: 0032819870     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923979909007123     Document Type: Article

References (52)

1. Ridley, D.S., In The Leishmaniasis in Biology and Medicine, edited by : W Peters, R Killick-Kendrick, p. 665, Academic Press, London:, 1987.
2. Reiner, S. L. and Locksly, R. M., The regulation of immunity to Leishmania major. Ann. Rev. Immunol., 13:151, 1995.
3. Liew, F. Y. and O'Donnell C. A., Immunology of leishmaniasis. Adv. Parasitol., 13:161, 1993.
4. Blalock, J. E., A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol. Rev., 69:1, 1989.
5. Goetzl, E. J., Adelman, D. C. and Sreedharan S. P. Neuroimmunology. Adv. Immunol., 48:161, 1990.
6. Payan, D. G., Brewster D.R. and Goetzl E. J. Specific stimulation of human T lymphocytes by substance P. J. Immunol., 131:1613, 1983.
7. Rola-Pleszczynski M., Bolduc, D. and St-Pierre, S. The effect of vasoactive intestinal peptide on human natural killer cell function. J. Immunol., 135:2569, 1985.
8. Umeda, Y. And Arisawa, M. Inhibition of natural killer activity by calcitonin gene -related peptide. Immunopharmacol. Immunotoxicol.,11:309, 1989.
9. Ottaway, C. A. And Greenberg, G. R. Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen response. J. Immunol., 132:417, 1984.
10. Payan, D. G., Hess, C.A. and Goetzl, E. J. Inhibition by somatostatin of the proliferation of T lymphocytes and Molt-4 lymphoblasts. Cell. Immunol., 84:433, 1984.
11. Stanisz, A. M., Befus, D. and Bienenstock, J. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J. Immunol., 136:152, 1986.
12. Ottaway, C. A. Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells. Immunology, 62:291, 1987.
13. Scicchitano, R., Bienenstock, J. and Stanisz, A. M. In vivo immunomodulation by neuropeptide substance P. Immunology, 63;733, 1988.
14. Umeda, Y., Takamya, M., Yoshizaki, H. and Arisawa, M. Inhibition of mitogen stimulated T lymphocyte proliferation by calcitonin gene-related peptide. Biochem. Biophys. Res. Commun., 154:227, 1988.
15. Moore, T. C. Modification of lymphocyte traffic by vasoactive neurotransmitter substances. Immunology, 52:511, 1984.
16. Ottaway, C. A. In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells. J. Exp. Med., 160:1054, 1984;.
17. Moore, T. C., Spruck, C. H. and Said, S. I. Depression of lymphocyte traffic in sheep by vasoactive intestinal peptide (VIP). Immunology, 64:475, 1988.
18. Ahmed, A. A., Wahbi, A-H., Nordlind, K., Kharazmi, A., Sundqvist, K-G., Mutt, V. and Lidén S. In vitro Leishmania major promastigote-induced macrophage migration is modulated by sensory and autonomic neuropeptides. Scand. J. Immunol., 48: 79, 1998.
19. Helme, R. D., Eglezos, A., Dandie, G. W., Andrews, P. V. and Boyd R. L. The effect of substance P on regional lymph node antibody response to antigenic stimulation in capsaicin-pretreated rats. J. Immunol., 139:3470, 1987.
20. Kimball, E. S., Persico, F. J. and Vaught, J. L. Substance P, neurokinin A, and neurokinin B induce generation of IL-1-like activity in P388DI cells. Possible relevance to arthritic disease. J. Immunol., 141:3564, 1988.
21. Lotz, M., Vaughan, J. H. and Carson, D. A. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science, 241:1218, 1989.
22. Koff, W. and Dunegan, M. A. Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J. Immunol., 135:350, 1985.
23. Hartung, H.P., Wolters, K. and Toyka, K. V: Substance P: binding properties and studies on cellular responses in guinea pig macrophages. J. Immunol., 136:3856, 1986.
24. Nong, Y. H., Titus, R.G., Ribeiro, J. M. C. and Remold, H. G. Peptides encoded by the calcitonin gene inhibit macrophage function. J. Immunol. 143:45, 1989.
25. Wiik, P. Vasoactive intestinal peptide inhibits the respiratory burst in human monocytes by a cyclic AMP-mediated mechanism. Regul. Pept. 25:187, 1989.
26. Ahmed, A. A., Mahmood, A., Theodorsson, E. and Nordlind, K. Decreased concentrations of CGRP in Leishmania major murine cutaneous leishmaniasis. Neurosci. Lett., 246:149, 1998.
27. Ahmed, A. A., Mahmood, A., Theodorsson, E. and Nordlind, K. NPY concentrations in experimental Leishmania major cutaneous leishmaniasis. NeuroReport, 9:3271, 1998.
28. Louis, J. A., Moedder, E. and Behin, H. D. Regulation of protozoan parasite antigens by murine T lymphocytes: 1. Induction of specific T lymphocyte dependent proliferative response to Leishmania tropica. Eur. J. Immunol., 9:841, 1979.
29. Said, S. I. And Mutt V. Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur. J. Biochem., 28:199, 1972.
30. Yang, X. and HayGlass, K. I. A simple, sensitive, dual mAb ELISA for murine gamma interferon determination: comparison with two common bioassays. J. Immunoassay, 14:129, 1993.
31. Montgomery DC. Design and analysis of experiments, John Wiley & Sons, New York 1991.
32. Bogdan, C., André, G. And Röllinghoff, M. Cytokines in leishmaniasis: a complex network of stimulatory and inhibitory interactions. Immunobiology, 189:356, 1993.
33. Bogdan, C., Stenger, S., Röllinghoff, M. and Salbach, W. Cytokine interactions in experimental cutaneous leishmaniasis: interleukin-4 synergizes with interferon-γ to activate murine macrophage for killing of Leishmania major amastigotes. Eur. J. Immunol., 21:327, 1991.
34. Agro, A., Padol, I. and Stanisz, A. M. Immunomodulatory activities of somatostatin analogue BIM 23014c: effects on murine lymphocyte proliferation and natural killer cell activity. Regul. Pept., 32:129, 1991.
35. Malec, P., Zeman, K., Markiewicz, K., Tchôrzewski, H., Nowak, Z. And Baj, Z. Short-term somatostatin infusion affects T lymphocyte responsiveness in humans. Immunopharmacology, 17:45, 1989.
36. Muscettola, M. and Grasso, G. Somatostatin and vasoactive intestinal peptide reduce interferon gamma production by human peripheral blood mononuclear cells. Immunobiology, 180:419, 1990.
37. Sreedharan, S. P., Kodama, K. T., Peterson, K. E. and Goetzl, E. J. Distinct subsets of somatostatin receptors on cultured human lymphocytes. J. Biol. Chem., 264:949, 1989.
38. Hiruma, K., Koike, I., Nakamura, H., Sumida, T., Maeda, T., Tomiok, A., Yoshida, S. and Fujita, T. Somatostatin receptors on human lymphocytes and leukaemia cells. Immunology, 71:480, 1990.
39. Scicchitano, R., Dazin, P., Bienenstock, J., Payan, D. G. and Stanisz, A. M. Distribution of somatostatin receptors on murine spleen and Peyer's patch T and B lymphocytes Brain Behav. Immun., 1:173, 1987.
40. Umeda, Y. Inhibition of immune response by CGRP. Ann. N. Y. Acad. Sci., 657:552, 1992.
41. Owan, I., Ibaraki, I. The role of calcitonin gene-related peptide (CGRP) in macrophages: the presence of functional receptors and effects on proliferation and differentiation into osteoclast-like cells. Bone & Mineral, 24:151, 1994.
42. McGillis, J., Mitsuhashi, M. and Payan, D., In Psychoneuroimmunology, edited by: R. Ader, D. Felten and N. Cohen, p. 209, Academic Press, San Diego, 1991.
43. Kincy-Cain, T. and Bost, K. L. Substance P-induced IL-12 production by murine macrophages. J. Immunol.,158:2334, 1997.
44. Clementi, G., Caruso, A., Cutuli, V. M. C., Prato, A., Bernardis, E., Fiore, C. E. and Amico-Roxas. Anti-inflammatory activity of amylin and CGRP in different experimental models of inflammation. Life Sci., 57PL:193, 1995.
45. Ganea, D. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs. Adv. Neuroimmunol., 6: 61, 1996.
46. Lundeberg, L., Mutt, V. and Nordlind, K. Inhibitory effect of vasoactive intestinal polypeptide on the challenge phase of allergic contact dermatitis. Accepted for publication in Acta. Derm. Venereol., (Stockh).
47. Weinstock, J. V. Vasoactive intestinal peptide regulation of granulomatous inflammation in murine Schistosomiasis mansoni. Adv. Neuroimmunol. 6:95, 1996.
48. Sun, L. and Ganea, D. VIP inhibits IL-2 and IL-4 production through different mechanisms in T cells activated via the TCR/CD3 complex. J. Neuroimmunol., 6:95, 1993.
49. Xin, Z., Tang, H. and Ganea, D. VIP inhibits IL-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex. J. Neuroimmunol., 54:59,1994.
50. Morris, L., Troutt, A. B., McLeod, K. S., Kelso, A., Handmann, E. and Aebischer, T. Interleukin-4 but not gamma interferon production correlates with severity of murine cutaneous leishmaniasis. Infect. Immun. 61:3459, 1993.
51. Schwarz, H., Villiger, P. M., Kempis, J. and Lotz, M. Neuropeptide Y is an inducible gene in the human immune system. J. Neuroimmunol., 51:53, 1994.
52. Agro, A. and Stanisz, A. M. Neuroimmunomodulation: classical and non-classical cellular activation. Adv. Neuroimmunol., 5:311, 1995.